Drug intelligence / Profile preview

Yinlian gargle

Development stage: Preclinical
Lead developer: First Affiliated Hospital of Guangzhou University of Chinese Medicine
Modality: Small Molecules
Administration: Oral

Overview

Yinlian gargle is a preparation, likely derived from traditional Chinese medicine, currently under investigation for its therapeutic potential in chronic periodontitis. It is being studied for its effects on the biological behavior of human gingival fibroblasts when stimulated by lipopolysaccharide from Porphyromonas gingivalis, suggesting a mechanism involving modulation of cellular responses to bacterial toxins and inflammation.

Other names: Yinlian

Beyond the preview

Go deeper on Yinlian gargle.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yinlian gargle.

Explore the full profile